24 Hrs
Source:
الاتحاد
Gulfar reports half-year revenue of 573.7M AED
Gulf Pharmaceutical Industries "Gulfar" announced that its revenues from ongoing operations increased to 573.7 million dirhams in the first half of 2026, representing an annual growth rate of 4.7% compared to the same period in 2025. The company has achieved continuous profit growth, with improvements in profit margins and a significant 84.7% increase in Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), totaling 86.8 million dirhams, despite global challenges such as geopolitical uncertainties, supply chain disruptions, and inflation. The results also indicated that the company continues to strengthen its financial position, with shareholders’ equity rising to 1,016 million dirhams. It is also continuing its expansion into key markets like Saudi Arabia, launching new products, and obtaining international registrations to enhance its position and expand its market share.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)